Switch to:
More From Other Websites
Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog Jan 28 2015
Biotech Stocks Down Despite Strong Amgen Quarter Jan 28 2015
Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog Jan 27 2015
Momenta Pharmaceuticals Done In by Delay Jan 26 2015
[$$] Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug Jan 26 2015
Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog Jan 26 2015
Teva's generic version of AstraZeneca's Nexium gets FDA approval Jan 26 2015
Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States Jan 26 2015
Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States Jan 26 2015
Teva’s Sell Rating From Berenberg Bucks Bullish View on Copaxone Jan 26 2015
Pfizer’s Deal Hunt Included Rebuffed Teva Approach Jan 23 2015
Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog Jan 21 2015
[$$] Supreme Court Sides With Teva in Patent Case Jan 21 2015
Teva, Microsoft, Nestle, Uber: Intellectual Property Jan 21 2015
Teva Pharmaceutical Jan 20 2015
A Court Ruling Gives Teva how Much Time to Avoid Generic Copaxone? Jan 20 2015
Supreme Court Hands Trial Courts More Power In Teva Patent Case Jan 20 2015
Sterne Agee Analyst: Court Win To Boost Net At Teva Pharmaceutical Jan 20 2015
Midday movers: Teva, Outerwall, Tiffany & more Jan 20 2015
U.S. Supreme Court rules for Teva over MS drug patent Jan 20 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK